Blocking platelet-activating factor reduces liver damage in cirrhosis
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
Brain function discovery helps explain why childhood adversity raises metabolic disease risk in women
McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
GPR120 plays a key role in mediating the effects of n-3 fatty acids on mammary function
Background During lactation, the mammary gland undergoes significant structural and functional changes to produce milk, which is essential…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Scientists uncover brain circuit that turns cravings into eating behavior
Scientists uncovered how the brain’s bed nucleus of the stria terminalis acts as a master switchboard, merging reward…
Genetic variants mimicking IL-6 inhibition linked to lower cardiovascular risk
People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering…
Genetic variants influencing vitamin D synthesis, metabolism, and transport
From skin tone to rare mutations, scientists uncover how your genes influence vitamin D levels, and why standard…
High-Dose vitamin D for VLBW infants
Doubling the vitamin D dose for premature, very low birth weight infants can safely give their tiny bones…
Which GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answers
A deep dive into public Facebook posts uncovers the real-world side effect patterns of GLP-1 medications, revealing what…